Insider · CIK 0001202785

DOBMEIER ERIC

Reports to the SEC for 9 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001202785

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+39.5K sh	—	—	39,453
2026-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2026-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+5,500 sh	—	—	15,481
2026-06-09	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34.8K sh	—	—	34,843
2025-06-23	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+51.8K sh	—	—	51,804
2025-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.7K sh	—	—	11,667
2025-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+3,750 sh	—	—	9,981
2025-04-29	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,017
2024-07-19	JANXJanux Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,700
2024-07-19	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+1,231 sh	—	—	6,231
2024-07-19	JANXJanux Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,111 sh	—	—	4,111
2024-07-19	JANXJanux Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,350 sh	—	—	8,350
2024-07-19	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+2,500 sh	—	—	7,500
2024-07-19	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-06-25	GPCRStructure Therapeutics Inc. · Share Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2023-11-10	ATRAAtara Biotherapeutics, Inc.P Purchase	Director	PPurchase	+447K sh	$0.23	+$101K	563,325
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−11.3K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−353K sh	$39.65	−$14M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−30.8K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−50K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−255K sh	$14.73	−$3.76M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−64.1K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−179K sh	$24.86	−$4.44M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−314K sh	$39.58	−$12.4M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−272K sh	$25.23	−$6.85M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−300K sh	$27.10	−$8.13M	0
2023-08-11	CHINOOK THERAPEUTICS, INC.D Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−301K sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsD Disposition to Issuer	Director, President, CEO	DDisposition to Issuer	−20.2K sh	—	—	0
2023-05-31	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+57K sh	—	—	116,500
2023-05-31	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+79.5K sh	—	—	79,500
2023-04-24	CHINOOK THERAPEUTICS, INC.S Sale	Director, President, CEO	SSale	+1,200 sh	$22.26	+$26.7K	301,138
2023-04-24	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+25K sh	$0.42	+$10.5K	326,138
2023-04-24	CHINOOK THERAPEUTICS, INC.S Sale	Director, President, CEO	SSale	−23.8K sh	$21.58	−$514K	302,338
2023-04-24	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−25K sh	—	—	313,555
2023-02-10	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+20.2K sh	—	—	309,235
2023-02-10	CHINOOK THERAPEUTICS, INC.S Sale	Director, President, CEO	SSale	−8,097 sh	$23.75	−$192K	301,138
2023-02-10	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsM Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−20.2K sh	—	—	20,248
2023-01-31	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitA Award	Director, President, CEO	AAward	+64.1K sh	—	—	64,050
2023-01-31	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+25K sh	—	—	296,675
2023-01-31	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director, President, CEO	AAward	+255K sh	—	—	255,150
2023-01-31	CHINOOK THERAPEUTICS, INC.S Sale	Director, President, CEO	SSale	−7,688 sh	$24.68	−$190K	288,987
2023-01-31	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitM Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−25K sh	—	—	50,001
2023-01-30	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+25K sh	$0.42	+$10.5K	296,676
2023-01-30	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−25K sh	—	—	338,555
2023-01-30	CHINOOK THERAPEUTICS, INC.S Sale	Director, President, CEO	SSale	−25K sh	$24.54	−$614K	271,676
2022-12-14	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−30K sh	—	—	353,358
2022-12-14	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	+30K sh	$0.35	+$10.5K	271,676
2022-12-01	CHINOOK THERAPEUTICS, INC.S Sale	Director, President, CEO	SSale	−30K sh	$22.31	−$669K	241,676
2022-12-01	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director, President, CEO	MExercise/Conversion	−60K sh	—	—	363,555
2022-12-01	CHINOOK THERAPEUTICS, INC.G Gift	Director, President, CEO	GGift	−25K sh	—	—	211,676

Recent filings

Accepted (ET)
Jun 184
DOBMEIER ERIC0001202785-26-000004
SEC(opens sec.gov)
Jun 124
DOBMEIER ERIC0001202785-26-000002
SEC(opens sec.gov)
Jun 114
DOBMEIER ERIC0001193125-26-267739
SEC(opens sec.gov)
Jun 254
DOBMEIER ERIC0001415889-25-018215
SEC(opens sec.gov)
Jun 134
DOBMEIER ERIC0001415889-25-017315
SEC(opens sec.gov)
May 14
DOBMEIER ERIC0000950170-25-062091
SEC(opens sec.gov)
Jul 244/A
DOBMEIER ERIC0001415889-24-020057
SEC(opens sec.gov)
Jul 224
DOBMEIER ERIC0001415889-24-019904
SEC(opens sec.gov)
Jun 274
DOBMEIER ERIC0001415889-24-018326
SEC(opens sec.gov)
Nov 144
DOBMEIER ERIC0000905148-23-001449
SEC(opens sec.gov)
Aug 114
DOBMEIER ERIC0001209191-23-045417
SEC(opens sec.gov)

Companies

Address

C/O STRUCTURE THERAPEUTICS INC. 601 GATEWAY BLVD., SUITE 900

SOUTH SAN FRANCISCO, CA, 94080